Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations

SOX1 autoantibodies are considered markers of small cell lung cancer (SCLC) and paraneoplastic neurological syndromes (PNS) and are usually determined by commercial line blot in many clinical services. Recent studies suggested that SOX1 autoantibodies also occur in patients with neuropathies unrelat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-García, Raquel, Martínez-Hernández, Eugenia, García-Ormaechea, Milagros, Español-Rego, Marta, Sabater, Lidia, Querol, Luis, Illa, Isabel, Dalmau, Josep, Graus, Francesc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473043/
https://www.ncbi.nlm.nih.gov/pubmed/31031763
http://dx.doi.org/10.3389/fimmu.2019.00769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473043/
https://www.ncbi.nlm.nih.gov/pubmed/31031763
http://dx.doi.org/10.3389/fimmu.2019.00769

Ejemplares similares